Importantly, co-immunoprecipitation assays have identified a new AHI-1-BCR-ABL-JAK2 interaction complex at endogenous levels in CML cells [19]. This evidence concerns the gene JAK2 and chronic myelogenous leukemia, BCR-ABL1 positive.